CPE vs Gin Hwa Biotech: monthly revenue

Monthly revenue and year-on-year change for CPE (1215) and Gin Hwa Biotech (7806) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ CPE ━ Gin Hwa Biotech

0%+42%-29%25/1026/0126/0426/0726/10

Monthly revenue history

MonthCPEYoYGin Hwa BiotechYoY
Oct 2026NT$2.66 billion+13.4%NT$35.7 million-9.0%
Sep 2026NT$2.54 billion+6.2%NT$47.7 million+41.5%
Aug 2026NT$2.36 billion+1.3%NT$45.7 million-8.6%
Jul 2026NT$2.56 billion+8.1%NT$44 million+27.0%
Jun 2026NT$2.42 billion+8.7%NT$48.8 million+13.5%
May 2026NT$2.49 billion+1.7%NT$48.4 million-0.7%
Apr 2026NT$2.32 billion-2.9%NT$49 million+12.6%
Mar 2026NT$2.51 billion+7.5%NT$55.4 million-29.0%
Feb 2026NT$2.03 billion+0.0%NT$33.8 million-7.9%
Jan 2026NT$2.63 billion+13.0%NT$46.8 million+37.1%
Dec 2025NT$2.75 billion+13.0%NT$49.1 million+16.9%
Nov 2025NT$2.48 billion+1.9%NT$47.8 million+29.1%
Oct 2025NT$2.35 billion-4.5%NT$39.2 million+14.3%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16